Sponsors of H.R. 4878 were thanked for efforts to amend the Social Security Act to provide better health care to patients with chronic medical conditions. Read More »

AstraZeneca and its R&D arm, MedImmune, to present abstracts, oral presentations and lectures in New Orleans. Read More »

The annual spring conference featured solutions to the changing landscape in health care delivery systems. Read More »

CPC+ supports primary care doctors; promotes high-quality care for patients. Read More »

Chronic migraine, limb spasticity and Alzheimer's are on the schedule at the Vancouver meeting. Read More »

Walgreens makes lifesaving medication available at more than 120 pharmacies in Pennsylvania. Read More »

IMS Health study shows increase in medication spending, up 8.5 percent between 2014 and 2015 Read More »

NACDS-backed bill passes Senate and House; next step is the President's signature. Read More »

The Phase III SIERRA clinical trial will test effectiveness of Iomab-B when used prior to bone marrow transplants. Read More »

Various states have enacted or are considering legislation limiting the circumstances under which maximum allowable cost programs (MACs) may be used, a decision that one expert says could result in increased pharmaceutical spending that in turn increases the cost of pharmaceutical coverage. Read More »

Concerns expressed to FDA about possibility of price increases and conflicting labels on generic drugs. Read More »

Industry professional Mike Kelly joins Adapt Pharma; takes over U.S. operating activities. Read More »

The online training helps health care professionals find ways to motivate patients to change health behaviors. Read More »

Trial data on Verseon's anti-coagulant drug family presented in Stockholm last week. Read More »

The pharmaceutical wholesale business was sold to 36.6, a Russian health and beauty retailer. Read More »

Dr. Vivek Murthy started his prescription drug crisis tour in Baltimore on April 5. Read More »

Potential treatment for early Alzheimer's disease to continue without modification to Phase III. Read More »

Amgen recently announced its win against Sanofi and Regeneron Pharmaceuticals. Read More »

NACDS and NCPA urge Congress to reduce TRICARE costs. Read More »

McKesson recently announced that it has been awarded a $139 million, five-year contract from the Department of Defense and the Defense Health Agency for its patient engagement and interoperable secure messaging solution, RelayHealth. Read More »